Silo Pharma (SILO) Total Debt (2012 - 2023)
Silo Pharma (SILO) posted Total Debt of $660279.0 for Q1 2023, up 81.29% sequentially from $364216.0 in Q4 2022, and up 918.34% YoY from $64839.0 in Q1 2022.
Silo Pharma (SILO) Total Debt (2012 - 2023) Analysis & Trends
Silo Pharma has reported Total Debt for 6 years, with the latest figure at $660279.0 in Q1 2023.
- Quarterly Total Debt rose 918.34% year-over-year to $660279.0 in Q1 2023, while the trailing twelve-month figure through Mar 2023 was $660279.0 (up 918.34% YoY) and the FY2022 annual result came in at $364216.0, down 12.85% from the prior year.
- Total Debt climbed to $660279.0 in Q1 2023 per SILO's latest filing, from $364216.0 in the prior quarter.
- Over five years, Total Debt peaked at $660279.0 in Q1 2023 and troughed at $3429.0 in Q1 2021.
- A 4-year average of $148125.1 and a median of $52829.0 in 2022 frame the typical range for Total Debt.
- The sharpest annual moves came in 2021 and 2022: Total Debt soared 9743.08% in 2021, then sank 81.93% in 2022.
- Over 4 years, Total Debt stood at $4246.0 in 2020, then jumped by 9743.08% to $417937.0 in 2021, then slipped by 12.85% to $364216.0 in 2022, then soared by 81.29% to $660279.0 in 2023.
- According to Business Quant data, Total Debt over the past three periods registered $660279.0, $364216.0, and $16447.0 for Q1 2023, Q4 2022, and Q3 2022 respectively.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Total Debt (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 140.23 Bn | 132.38 Bn | 2.84 Bn | - |
| 2 | Regeneron Pharmaceuticals | 86.97 Bn | 78.97 Bn | 3.93 Bn | 1.99 Bn |
| 3 | Argenx Se | 65.29 Bn | 60.11 Bn | 1.37 Bn | - |
| 4 | Moderna | 59.88 Bn | 54.74 Bn | 52.00 Mn | 591.00 Mn |
| 5 | BeOne Medicines | 42.20 Bn | 37.11 Bn | 1.53 Bn | 1.07 Bn |
| 6 | Alnylam Pharmaceuticals | 31.62 Bn | 28.31 Bn | 992.69 Mn | - |
| 7 | BioNTech SE | 28.69 Bn | 10.30 Bn | 668.28 Mn | 770.36 Mn |
| 8 | Insmed | 27.51 Bn | 26.35 Bn | 358.27 Mn | 546.77 Mn |
| 9 | Royalty Pharma | 27.16 Bn | 26.33 Bn | - | 9.34 Bn |
| 10 | Silo Pharma | 3.08 Mn | 3.08 Mn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2023 | 660,279.00 |
| Dec 31, 2022 | 364,216.00 |
| Sep 30, 2022 | 16,447.00 |
| Jun 30, 2022 | 40,819.00 |
| Mar 31, 2022 | 64,839.00 |
| Dec 31, 2021 | 417,937.00 |
| Sep 30, 2021 | 91,003.00 |
| Jun 30, 2021 | 91,002.00 |
| Mar 31, 2021 | 3,429.00 |
| Dec 31, 2020 | 4,246.00 |
| Sep 30, 2020 | 11,642.00 |
| Jun 30, 2020 | 11,642.00 |
| Dec 31, 2013 | 15,000.00 |
| Dec 31, 2012 | 20,000.00 |
| Sep 30, 2012 | 15,000.00 |
| Jun 30, 2012 | 15,000.00 |
| Mar 31, 2012 | 15,000.00 |